Vistin Pharma ASA: Third quarter and YTD 2024 financial results
Oslo, Norway, 31st of October 2024…
2,045€
1,24%
Echtzeit-Aktienkurs VISTIN PHARMA ASA NK 1
Bid:
Ask:
Nachrichten zur VISTIN PHARMA ASA NK 1 Aktie
Vistin Pharma ASA: Mandatory notification of trade
Saga Pure ASA has on 23 August 2024 purchased 300,000 shares in Vistin Pharma ASA at NOK 22,50 per share.…
Vistin Pharma ASA: Second quarter and first half 2024 financial results
Oslo, Norway, 23rd of August 2024…
Ex dividend NOK 0.50 today
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 05.06.2024.…
Vistin Pharma ASA: Minutes from the annual general meeting 2024
Oslo, Norway, 23 May 2024…
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024
Oslo, Norway, 30 April 2024…
Vistin Pharma ASA: Annual Report 2023
Oslo, Norway, 24 April 2024…
Vistin Pharma ASA: First quarter 2024 financial results
Oslo, Norway, 24th of April 2024…
Vistin Pharma ASA: Mandatory notification of trade
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of…
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
Oslo, Norway, 4 March 2024…
Vistin Pharma ASA: Key information relating to the proposed cash dividend
The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00…
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
Oslo, Norway, 16th of February 2024…
Vistin Pharma ASA: Invitation to Q4 2023 conference call
Oslo, Norway, 9 February 2024…
Ex dividend NOK 0.75 today
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.…
Key information relating to the cash dividend to be paid by Vistin Pharma ASA
Dividend amount (per share): NOK 0.75…
Vistin Pharma ASA: Dividend of NOK 0.75 per share
Oslo, Norway, 11 January 2024…
Vistin Pharma ASA: Third quarter 2023 financial results
Oslo, Norway, 25th of October 2023…
Vistin Pharma ASA: New CEO appointed
Oslo, Norway, 25th of October 2023…
Vistin Pharma ASA: Mandatory notification of trade
Saga Pure ASA has on 18 September 2023 purchased 100,000 shares in Vistin Pharma ASA at NOK 23,50 per share.…
Mandatory notification of trade in Vistin Pharma ASA
Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per…
Vistin Pharma ASA: Second quarter and first half 2023 financial results
Oslo, Norway, 23rd of August 2023...…
Vistin Pharma ASA: Invitation to Q2 2023 conference call
Oslo, Norway, 16 August 2023...…
Management in Vistin Pharma ASA purchases shares
4 July 2023: Vistin Pharma ASA (the “Company”) has on 4 July 2023 sold shares to members of its management…
Vistin Pharma ASA: Results of offer to buy back shares
4 July 2023: Reference is made to the stock exchange release of Vistin Pharma ASA (“Vistin” or the "Company") dated…
Vistin Pharma ASA: Offer to buy back shares
30 June 2023: Vistin Pharma ASA (the “Company”) has decided to launch an offer to all shareholders in the Company…
Vistin Pharma ASA: Mandatory notification of trade
Magnus Tolleshaug, Chief Commercial Officer in Vistin Pharma ASA, and a primary insider, has on 31st of May 2023 purchased…
Vistin Pharma ASA: Minutes from the Annual General Meeting 2023
Oslo, Norway, 22 May 2023...…
Disclosure of voting rights at AGM in Vistin Pharma ASA
In relation to the Annual General Meeting in Vistin Pharma ASA on the 22nd of May, the Companys Chair of…
Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø
Vistin Pharma will host a Capital Markets Day (CMD) for all interested parties on the 14th of June at its…
Notice of Annual General Meeting in Vistin Pharma ASA
Oslo, Norway, 28 April 2023...…
Vistin Pharma ASA: Annual Report for 2022
Oslo, Norway, 27 April 2023...…
Vistin Pharma ASA: First quarter 2023 financial results
Oslo, Norway, 27th of April 2023...…
Vistin Pharma ASA: Invitation to Q1 2023 conference call
Oslo, Norway, 20 April 2023...…
Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results
Oslo, Norway, 17th of February 2023...…
Vistin Pharma ASA: Invitation to Q4 2022 conference call
Oslo, Norway, 10 February 2023...…
Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft
Oslo, Norway, 9 December 2022...…
Vistin Pharma ASA: Third quarter and YTD 2022 financial results
Oslo, Norway, 26th of October 2022...…
Vistin Pharma ASA: Invitation to Q3 2022 conference call
Oslo, Norway, 18 October 2022...…